FMP

FMP

Enter

PAVM - PAVmed Inc.

Financial Summary of PAVmed Inc.(PAVM), PAVmed Inc. operates as a medical device company in the United States. The company's lead products i

photo-url-https://financialmodelingprep.com/image-stock/PAVM.png

PAVmed Inc.

PAVM

NASDAQ

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

0.99 USD

-0.07 (-7.07%)

About

ceo

Dr. Lishan Aklog M.D.

sector

Healthcare

industry

Medical - Devices

website

https://www.pavmed.com

exchange

NASDAQ

Description

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and...

CIK

0001624326

ISIN

US70387R4039

CUSIP

70387R106

Address

One Grand Central Place

Phone

212 949 4319

Country

US

Employee

107

IPO Date

Jul 27, 2016

Summary

CIK

0001624326

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

70387R106

ISIN

US70387R4039

Country

US

Price

0.99

Beta

0.72

Volume Avg.

62.28k

Market Cap

9.34M

Shares

-

52-Week

0.9712-9.0

DCF

-0.01

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.11

P/B

-

Website

https://www.pavmed.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest PAVM News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep